1079760

Eversight — FEI 3001236615

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 19, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Clark, NJ (United States)

Citations

IDCFRDescription
1223021 CFR 1271.50(a)Responsible person to determine, document
1223621 CFR 1271.55(a)(2)Eligibility statement--basis of determination